Mirum Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MIRM and other ETFs, options, and stocks.About MIRM
Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. The firm focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases.
MIRM Key Statistics
Stock Snapshot
As of today, Mirum Pharmaceuticals(MIRM) shares are valued at $83.92. The company's market cap stands at 5.44B, with a P/E ratio of -5.77.
During the trading session on 2026-10-02, Mirum Pharmaceuticals(MIRM) shares reached a daily high of $86.17 and a low of $83.68. At a current price of $83.92, the stock is +0.3% higher than the low and still -2.6% under the high.
Trading volume for Mirum Pharmaceuticals(MIRM) stock has reached 641.71K, versus its average volume of 889.2K.
Over the past 52 weeks, Mirum Pharmaceuticals(MIRM) stock has traded between a high of $130.00 and a low of $63.23.
Over the past 52 weeks, Mirum Pharmaceuticals(MIRM) stock has traded between a high of $130.00 and a low of $63.23.
MIRM News
...
Mirum Pharmaceuticals ( (MIRM) ) has shared an announcement. On September 25, 2026, Mirum and Incyte announced U.S. FDA approval of Atebrioz tablets, a once‑da...
Mirum Pharmaceuticals (MIRM) announced the primary endpoint was met in the Phase 3 portion of the AZURE-1 study evaluating brelovitug, an investigational fully...
Analyst ratings
100%
of 14 ratingsMore MIRM News
Mirum Pharmaceuticals (MIRM) and Incyte (INCY) announced that the U.S. FDA has approved Atebrioz tablets to reduce the volume of total new heterotopic ossificat...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.